COVID-19 / Coronavirus

Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China

2021-04-15 18:20 917

SUZHOU, China, April 15, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (stock code 9939.HK, "Kintor Pharmaceutical" or the "Company"), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that it has received approval from t...

LightAir IonFlow fights the spread of COVID-19

2021-04-15 17:45 581

STOCKHOLM, April 15, 2021 /PRNewswire/ -- LightAir IonFlow virus inhibitor is scientifically and independently proven on viruses in the air and on surfaces, and together with the development of vaccines, can actively contribute to halting the spread of COVID-19. New tests from a leading European...

New clinical study shows JOYSBIO COVID-19 neutralizing antibody rapid test nearly 98% accurate in verifying antibodies after vaccination

2021-04-15 14:20 448

TIANJIN, China, April 15, 2021 /PRNewswire/ -- In a major breakthrough for testing COVID-19 immunity, JOYSBIO, a Chinese medical device manufacturer, just announced the completion of a clinical study inItaly, showing their COVID-19 neutralizing antibody rapid test kit is 98.05% effective in detec...

Seegene's Italy subsidiary secures public procurement for 7.15 million COVID-19 diagnostic tests, the largest tender in history

2021-04-15 14:19 595

* Seegene's Italian subsidiary to supply some 7.15 million COVID-19 tests to 17 regions there * S. Korean biotechnology firm to expand its influence in Italy's PCR diagnostic industry SEOUL, South Korea, April 15, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading molecular diagnostics ...

Kintor Pharmaceutical and Visum Announced Strategic Partnership to Expand Proxalutamide Manufacturing

2021-04-14 22:18 1731

SUZHOU, China, April 14, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (stock code 9939.HK, "Kintor Pharmaceutical" or the "Company"), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, recently announced a strategic partnership with Hain...

BioVaxys Announces Final Clinical trial results of HPV product from EU partner ProCare Health Iberia published by American Society for Colposcopy and Cervical Pathology

2021-04-14 20:00 2137

VANCOUVER, BC, April 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:LMNGF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and cancers applications, is pleased to announce the results of a clinical study conducted by ProCare Health Iberia...

Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume COVID-19 Testing Receives CE Mark; Allows for More Convenient Sample Collection and Expanded Viral Transport Media

2021-04-13 21:00 2399

RARITAN, N.J., April 13, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics  (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its VITROS® SARS-CoV-2 Antigen Test, initially launched in October 2020. The CE Mark allows for ...

Aon Launches Innovative Industry Collaboration to Protect Global COVID-19 Vaccine Shipments

2021-04-13 21:00 2514

CHICAGO, April 13, 2021 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and health solutions, today introduced a new solution, through broad industry collaboration, that will provide supply chain protection for global CO...

Happiness Biotech Announces Record-High Sales of Over $14 Million On Its E-Commerce Business In March

2021-04-13 20:00 2293

NANPING, China, April 13, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer and e-commerce services provider, announced today that the Company's e-commerce business recorded sales of over$1...

Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public

2021-04-13 19:30 423

PISCATAWAY, New Jersey and WEST SACRAMENTO, Calif., April 13, 2021 /PRNewswire/ --Molecular Matrix, Inc.  (MMI) and GenScript Biotech Corp . announced today that they have partnered to offer GenScript's SARS-CoV-2 neutralizing antibody t...

MGI COVID-19 Container Lab Put to Test, Safeguarding the World Figure Skating Championships

2021-04-13 14:32 452

STOCKHOLM, April 13, 2021 /PRNewswire/ -- The weeklong ISU World Figure Skating Championships (the Championships), an Olympic qualification event, were held in Stockholm, Sweden in late March. The world's top figure skaters from around the world had travelled toSweden to compete for the title of w...

Hospital at Home Care Set to Make it Big in the United States with Strong Support from the Government

2021-04-13 00:30 968

Adoption of HaH model surged eight-fold in less than six months with the availability of advanced remote monitoring and digital health solutions, finds Frost & Sullivan SANTA CLARA, Calif., April 13, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Payment Reforms and Remote Care Deliver...

Seegene begins exporting its latest COVID-19 variant tests around the world to help contain spread of pandemic

2021-04-12 20:53 3094

* Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month SEOUL, South Korea, April 12, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology company specializing in molecular diagnostics, announced today that it has secured an export ...

AXA launches "Free Double Post-Vaccination Protection" Programme

2021-04-12 17:54 720

HONG KONG, April 12, 2021 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") launches the "Free Double Post-Vaccination Protection" Programme ("Programme") to provide free protection to customers against adverse event following immunisation ("AEFI"). From 1 April to30 June 2021, eligible customers[1...

Airway Therapeutics Announces FDA Acceptance of IND for AT-100's Second Indication in Severe COVID-19 Patients

2021-04-12 16:00 744

Initiating Phase 1b clinical trial with initial results expected 3Q2021 Potential for novel therapeutic AT-100 to inhibit viral replication, promote viral elimination and reduction of lung injury, inflammation, and secondary infections in severe COVID-19 patients CINCINNATI, April 12, 2021 /PRNe...

GenScript, Parkway Laboratories and Diagnostics Development (DxD) Hub collaborate to provide cPass(TM) SARS-CoV-2 Neutralizing Antibody Testing Service in Singapore

2021-04-12 13:00 1774

SINGAPORE, April 12, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test inSingapore through Parkway's pane...

Korea's Outstanding SMEs as Frontline Fighters against COVID-19

2021-04-12 09:00 1637

SEOUL, South Korea, April 12, 2021 /PRNewswire/ -- BSR Korea is encouraging and supporting decent and respectful domestic SMEs of prophylaxis industry to enter the global procurement-as-a-service market, as the government-entrusted organizing agency of the COVID-19 quarantine project, Marketing S...

Copan, putting Covid-19 challenges behind and setting up for the post-pandemic scenario

2021-04-10 01:43 2490

BRESCIA, Italy, April 10, 2021 /PRNewswire/ -- With an email to the main distributors, Copan group's CEO describes how the ramp-up of Covid-19-related products has been concluded, and how the company is now reorganizing to face post-pandemic challenges.

RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue

2021-04-09 19:00 3416

Independent Data Safety Monitoring Board unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 pneumonia based on review of unblinded safety data from the first 255 treated patients The 464-patient global Phase 2/3 COVID-19 study is ...

Seegene supports Mexico's 'back to school' campaign with COVID-19 tests and face masks

2021-04-09 04:08 223

SEOUL, South Korea, April 9, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm Seegene Inc. (KQ096530) said Friday it is supporting the Mexican government's push to return life to pre-pandemic days. Durin...

12345 ... 123